Sunderstorm, the California-based home of manufacturers behind KANHA and Lime, has signed a strategic settlement with New Backyard Pharma to supply EU‑GMP hashish edibles and flower for Europe and Australia, whereas increasing distribution with California’s Medical GmbH in Germany, FuGu Holdings in Australia, and Develop Group UK. As medical hashish markets in Europe and Asia-Pacific develop into multi‑billion‑greenback alternatives, KANHA is leveraging its established operations in Thailand and Japan to construct a totally built-in worldwide provide chain and ship quick‑appearing, exactly dosed merchandise to sufferers and wellness customers throughout 4 continents.
Learn the complete PR Newswire launch under for full particulars on the partnerships, market alternative, and KANHA’s plans to set a brand new international high quality benchmark in medical hashish.
LOS ANGELES, Feb. 25, 2026 /PRNewswire/ — Sunderstorm, a California-based chief in premium hashish merchandise and proprietor of the globally-recognized KANHA model, immediately introduced a strategic partnership with New Backyard Pharma, a licensed producer in North Macedonia, to additional broaden its international footprint into Europe and Australia. Sunderstorm can also be working with different international companions, together with California’s Medical GmbH in Germany, FuGu Holdings in Australia, and Develop Group UK in the UK. These partnerships mark the following part of Sunderstorm’s long-term international technique, specializing in entry into the worldwide medical-grade hashish market.
Based in California 10 years in the past, KANHA has been a premier and top-selling model within the U.S. for years. The model launched into its international enlargement technique three years in the past with its entry into Thailand and has established a presence throughout key worldwide markets, together with distribution in Europe, Japan, and Australia. These partnerships strengthen KANHA’s means to ship its premium merchandise into international markets whereas sustaining the standard and consistency that U.S. customers have loved for a few years.
By New Backyard Pharma’s EU-GMP facility in Skopje, North Macedonia, Sunderstorm will produce pharmaceutical‑grade hashish edibles tailor-made for distribution throughout Europe and Australia, whereas additionally collaborating on the commercialization of premium hashish flower and the joint improvement of revolutionary new product codecs. The partnership supplies the infrastructure, regulatory compliance, and manufacturing excellence required to fulfill the rigorous calls for of worldwide medical hashish markets.
Europe and Asia-Pacific characterize a number of the fastest-growing medical hashish markets on the planet. Europe’s medical market, valued at roughly US $3 billion in 2025, is projected to surge to US $13.16 billion by 2034, based on imarc. In the meantime, the medical market within the Asia-Pacific area, at the moment estimated at US $630 million, is anticipated to broaden to US $2.63 billion by 2033, based on Straits Analysis. With established operations in Asia and energetic distribution of hashish flower from Thailand into the UK, Germany, and Australian markets, KANHA is strategically positioned to serve sufferers and wellness customers at a pivotal second of accelerating worldwide entry and regulatory acceptance.
“KANHA is turning into one of many first actually international hashish manufacturers by coming into a number of the world’s most superior and extremely regulated medical markets,” mentioned Cameron Clarke, Co-founder and CEO of Sunderstorm. “For greater than a decade, we’ve constructed KANHA right into a top-tier model in america, and over the previous three years, we’ve laid the inspiration for a totally built-in worldwide provide chain. By our EU-GMP partnership with New Backyard Pharma and our distribution companions throughout Europe and Australia, we will now ship pharmaceutical-grade KANHA merchandise that meet essentially the most stringent international requirements. This enlargement marks a pivotal step in our evolution — from a number one U.S. hashish firm to a worldwide wellness platform serving sufferers throughout 4 continents.”
“Bringing KANHA to Europe via New Backyard Pharma’s EU-GMP manufacturing platform marks an vital step in increasing affected person entry to trusted, exactly formulated hashish merchandise,” mentioned Alexey Brylev, CEO of New Backyard Group. “By combining our EU-GMP infrastructure and built-in provide chain with Sunderstorm’s globally established KANHA model, we’re setting a brand new benchmark for high quality, reliability, and innovation within the worldwide medical hashish market.”
KANHA, one of many largest edible manufacturers in america, is acknowledged globally for its clear, high-quality, fast-acting formulations, exact dosing, and scientifically backed components. The model launched its international technique in Thailand in 2023 and Japan in 2025 via its three way partnership with Thai Stick Holdings and is now increasing its international footprint to serve Europe and Australia for each wellness and medical purposes.
“KANHA has an impressive popularity, and we’re proud to companion with them. They’ve constructed a tremendous operation in Thailand with growers and specialists from California and different elements of the U.S., ” mentioned Pierre Van Weperen from Develop Group UK. “We’re extremely excited to broaden our portfolio for UK sufferers and physicians, significantly with the introduction of the primary premium Thai-grown flower available in the market.”
About Sunderstorm
Based in 2015, Sunderstorm is a number one hashish home of manufacturers, house to the cult-favorite pre-roll line, Lime, and KANHA, a globally acknowledged edibles and vapes model. A premium market chief, KANHA is understood for category-defining innovation, together with the trade’s first fast-acting gummy and edibles backed by the model’s Contemporary Promise; a dedication to zero pesticides, rigorous testing, and nitrogen-flushed packaging for optimum freshness. Sunderstorm operates throughout key U.S. markets together with California, Nevada, Massachusetts, and Illinois, with increasing worldwide attain throughout Thailand, Japan, Europe, and Australia. KANHA’s hemp-derived gummies are additionally obtainable in 30+ extra U.S. states by way of kanhalife.com.
About New Backyard Pharma
New Backyard Pharma, the medical hashish subsidiary of New Backyard Group, is a number one European vertically built-in firm working to EU-GMP requirements. The corporate supplies end-to-end options throughout import, medical hashish flower processing, CO₂ extraction, and last dosage kinds manufacturing, supported by a strong and scalable supply-chain infrastructure.
About Develop Group UK
GROW Group UK is a number one importer, distributor, and producer of medical hashish within the UK, working since 2017. The corporate holds all required licenses—together with Schedule 1 and a medical trial license—enabling the import of bulk merchandise and uncooked supplies, in addition to native manufacturing. With a sustainable provide chain, a broad portfolio throughout value factors, and an increasing vary of hashish 2.0 merchandise, GROW Group UK helps docs and sufferers nationwide. The corporate additionally supplies a turnkey platform for brand new market entrants, providing full nationwide entry and aggressive manufacturing companies.
About California’s Medical GmbH
California’s Medical GmbH is a Germany-based pharmaceutical firm specializing within the import and distribution of medical hashish merchandise. The corporate holds EU-GMP certification for import and batch launch, operates absolutely in compliance with EU-GDP requirements, and maintains the required authorization underneath Germany’s MedCanG framework. With a deal with regulatory excellence, high quality assurance, and supply-chain reliability, California’s Medical is dedicated to making sure constant, secure, and compliant entry to medical hashish merchandise for sufferers in Germany.
About FuGu Holdings
Rooted deeply within the tradition and legacy of hashish, FuGu Holdings is redefining the Australian hashish market with a deal with uncommon and unique cultivars from artisan growers world wide. Based in 2024, FuGu Holdings has rapidly develop into one of many main firms domestically, having strategically partnered with distributors in each state, and plans for future enlargement into the USA, Thailand, and European Markets.
SOURCE Sunderstorm
